An Inherited Heteroplasmic Mutation in Mitochondrial Gene COI in a Patient with Prostate Cancer Alters Reactive Oxygen, Reactive Nitrogen and Proliferation

Rebecca S. Arnold(Emory University), Qian Sun(Emory University), Carrie Sun(Emory University), Jendai Richards(Emory University), Sean F. O’Hearn(University of California, Irvine), Adeboye O. Osunkoya(Emory University), Douglas C. Wallace(Children's Hospital of Philadelphia), John A. Petros(Emory University)
BioMed Research International
December 27, 2012
Cited by 739Open Access
Full Text

Abstract

Mitochondrial DNA (mtDNA) mutations have been found in many cancers but the physiological derangements caused by such mutations have remained elusive. Prostate cancer is associated with both inherited and somatic mutations in the cytochrome c oxidase (COI) gene. We present a prostate cancer patient-derived rare heteroplasmic mutation of this gene, part of mitochondrial respiratory complex IV. Functional studies indicate that this mutation leads to the simultaneous decrease in cytochrome oxidation, increase in reactive oxygen, and increased reactive nitrogen. These data suggest that mitochondrial DNA mutations resulting in increased reactive oxygen and reactive nitrogen generation may be involved in prostate cancer biology.


Related Papers

No related papers found

Powered by citation graph analysis